We serve Chemical Name:3-(Nitromethyl)cyclopentanone CAS:81266-47-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:3-(Nitromethyl)cyclopentanone
CAS.NO:81266-47-9
Synonyms:3-(Nitromethyl)cyclopentanone;Cyclopentanone, 3-(nitromethyl)-;3-(nitromethyl)cyclopentan-1-one
Molecular Formula:C6H9NO3
Molecular Weight:143.141
HS Code:2914700090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:279.8±13.0 °C at 760 mmHg
Density:1.2±0.1 g/cm3
Index of Refraction:1.481
PSA:62.89000
Exact Mass:143.058243
LogP:-0.39
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 3-(Nitromethyl)cyclopentanone chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-(nitromethyl)cyclopentan-1-one physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-(Nitromethyl)cyclopentanone Use and application,Cyclopentanone, 3-(nitromethyl)- technical grade,usp/ep/jp grade.
Related News: In March 2021, Reuters reported that a former Lilly human resources officer, Amrit Mula, had identified internally some of the same violations later documented by the FDA. Mula was forced out of the company in early 2019 after Lilly executives sought to downplay her findings, according to a letter demanding compensation for damages that her attorneys sent to the company. 3-(Nitromethyl)cyclopentanone manufacturer FT was defined as any difficulty paying medical bills, high financial distress, cost-related medication nonadherence, food insecurity, and/or foregone/delayed care due to cost. 3-(Nitromethyl)cyclopentanone supplier The mode of cooperation between domestic API companies and large international companies can lower the export threshold. 3-(Nitromethyl)cyclopentanone vendor In March 2021, Reuters reported that a former Lilly human resources officer, Amrit Mula, had identified internally some of the same violations later documented by the FDA. Mula was forced out of the company in early 2019 after Lilly executives sought to downplay her findings, according to a letter demanding compensation for damages that her attorneys sent to the company. 3-(Nitromethyl)cyclopentanone factory Retrogenix and Resonant Therapeutics, Inc. recently announced they have entered into a non-exclusive strategic partnership to identify the targets of Resonant antibodies directed against the tumor microenvironment.
